Literature DB >> 15616930

Urinary diversion in children with pelvic tumors.

D Ben Meir1, M Inoue, U Gur, P M Livne, Y Yaniv, K Tiedeman, D M Ashley, J M Hutson.   

Abstract

PURPOSE: The aim of this study was to investigate children presenting with malignant pelvic tumors obstructing the upper urinary tract.
METHODS: Seventeen children with upper urinary tract obstruction by a malignant tumor were reviewed. A nephrostomy tube or Double J (DJ) stent was inserted into each obstructed urinary system and removed after tumor shrinkage and/or hydronephrosis regression.
RESULTS: There were 9 boys and 8 girls in the study; the mean age and median follow-up were 5.7 years and 2.5 years, respectively. The most common obstructing tumor was rhabdomyosarcoma. Twelve children underwent diversion by nephrostomy tubes and 3 by DJ stents; 2 patients underwent resection of the tumors with ureteroureterostomy. Complications after the insertion of the stents included febrile urinary tract infections (UTI) or pyelonephritis in 4 of the children with DJ stents. In the nephrostomy group, febrile UTI developed in 3 and the tube fell out in 1, and was blocked in another. Of the 17 children, 9 have no evidence of disease, 2 are currently under treatment, and 6 died of cancer.
CONCLUSIONS: The prognosis of children with malignant pelvic tumor obstructing the upper urinary system justifies urgent and optimal upper tract diversion, enabling chemotherapy to be started immediately.

Entities:  

Mesh:

Year:  2004        PMID: 15616930     DOI: 10.1016/j.jpedsurg.2004.08.003

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  2 in total

Review 1.  Acute kidney injury due to bilateral ureteral obstruction in children.

Authors:  Daniele Bianchi; Giuseppe Vespasiani; Pierluigi Bove
Journal:  World J Nephrol       Date:  2014-11-06

Review 2.  Paediatric interventional oncology.

Authors:  D J Roebuck
Journal:  Cancer Imaging       Date:  2010-10-04       Impact factor: 3.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.